India Pharma Award 2022
TCS ADD™ Connected Clinical Trial platform received recognition for providing a unified, next-gen patient and site-centric offering
TCS ADD™ Connected Clinical Trial platform received recognition for providing a unified, next-gen patient and site-centric offering
TCS ADD™ Connected Clinical Trials is a comprehensive digital platform designed to transform the clinical trial landscape by addressing critical operational inefficiencies and enhancing stakeholder engagement.
Built with a focus on streamlining trial operations, the platform empowers pharmaceutical organizations to seamlessly oversee every stage of patient recruitment, screening, and enrollment while also giving holistic visibility on patients' journeys through the trial. Its automated screening capabilities leverage predefined criteria to identify suitable participants efficiently, reducing manual effort and accelerating timelines.
The patient recruitment and trial team gain visibility into recruitment progress via real-time tracking, allowing for data-driven adjustments and proactive management to ensure on-time enrollment. The integrated communication tools foster direct, timely interactions between the recruiters, the trial team, and participants, eliminating silos and fostering meaningful engagement throughout the clinical trial journey.
TCS ADD™ Connected Clinical Trials also offers advanced data integration with other clinical trial management systems, enabling organizations to unify workflows related to data management, advanced analytics, and patient engagement. By prioritizing digital connectivity, as evident through features like digital consenting, online diary submissions, and a comprehensive patient dashboard, TCS ADD™ Connected Clinical Trials elevates both patient and site experiences, ensuring that modern clinical studies are more informed, collaborative, and effective than ever before.
Pharmaceutical organizations today must navigate the dual imperative of delivering well-informed, patient-centered clinical trials while maximizing operational efficiency at trial sites. Legacy approaches, often characterized by fragmented systems and manual, paper-driven workflows, result in inefficiencies, delays, and suboptimal engagement for all stakeholders involved.
By contrast, a modern digital solution—built on comprehensive management of recruitment, automated screening, real-time tracking, integrated communication, seamless data integration, and advanced analytics—addresses these challenges head-on, streamlining processes and empowering both sponsors and sites to drive successful, timely clinical studies.
TCS helped Roche roll out an eConsent solution
Modern technologies, deep contextual expertise, and close collaboration with pharma organizations, patient advocacy groups, regulatory bodies, clinicians, and others alike combined with an ability to support adaptive (virtual, traditional, and hybrid) studies make TCS ADD™ Connected Clinical Trials, our decentralized trials platform, a preferred choice for trials worldwide.